Skip to content
stoqly

Alphatec Holdings, Inc.

ATEC Nasdaq Surgical & Medical Instruments & Apparatus Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$764M
25.0% vs prior year
Operating margin Operating income as a share of revenue.
βˆ’10.7%
11.5 pts
Net income Profit after all expenses, interest and tax.
βˆ’$143M
Free cash flow Cash from operations minus capital spending.
$2.8M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
βˆ’13.5%
11.9 pts
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On βˆ’$0.72 EPS (TTM)

What Alphatec Holdings, Inc. does

No business description yet.

Legal name
Alphatec Holdings, Inc.
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 24, 2026
Accession Β· CIK
0001193125-26-067393
0001350653

Revenue and margins

Alphatec Holdings, Inc. had $764M of revenue in fiscal 2025, up 25.0% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $2.8M in fiscal 2025, 0.4% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Alphatec Holdings, Inc. returned β€” to shareholders in fiscal 2025. The diluted share count rose 5.0%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Alphatec Holdings, Inc. can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $187M$84.7M$221M$139M$161M
Debt incl. finance leases $327M$379M$515M$578M$630M
Debt / equity 4.1xβ€”6.6xβ€”50.7x
Interest coverage βˆ’18.0xβˆ’26.7xβˆ’10.4xβˆ’5.5xβˆ’1.8x
Current ratio 3.3x1.8x2.9x2.7x2.1x
Quick ratio 2.4x1.1x2.0x1.6x1.3x
Total assets $572M$521M$805M$776M$791M
Total liabilities $491M$556M$727M$790M$779M
Shareholders' equity $80.7Mβˆ’$34.7M$78.1Mβˆ’$14.2M$12.4M
Net debt (βˆ’ = net cash) $140M$295M$294M$439M$470M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ•
Cash from operations is positive βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ“
Return on assets rose β€” βœ“ βœ• βœ• βœ“ βœ“ βœ• βœ“ βœ“ βœ“
Cash from operations exceeds net income βœ“ βœ• βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” βœ“ βœ“ βœ“ βœ“ βœ• βœ• βœ“ βœ• βœ•
Current ratio rose β€” βœ“ βœ“ βœ“ βœ“ βœ“ βœ• βœ“ βœ• βœ•
Share count didn't rise β€” βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ•
Gross margin rose β€” βœ“ βœ“ βœ• βœ“ βœ• βœ“ βœ• βœ“ βœ“
Revenue rose relative to assets β€” βœ• βœ• βœ• βœ• βœ• βœ“ βœ• βœ“ βœ“
F-score β€” / 34 / 94 / 93 / 95 / 93 / 93 / 94 / 94 / 95 / 9
Accruals ratio βˆ’21.2%7.2%βˆ’3.1%βˆ’16.0%βˆ’15.1%βˆ’16.7%βˆ’13.9%βˆ’16.3%βˆ’14.9%βˆ’24.1%
Altman Z'' βˆ’14.96βˆ’15.81βˆ’11.36βˆ’9.45βˆ’5.28βˆ’3.14βˆ’6.33βˆ’3.47βˆ’4.35βˆ’4.63

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $120M $102M $91.7M $113M $145M $243M $351M $482M $612M $764M
Gross profit $76.1M $68.2M $63.2M $77.6M $103M $158M $233M $310M $424M $532M
Research and development $9.2M $4.9M $9.9M $13.8M $18.7M $32.0M $44.0M $70.1M $80.7M $76.3M
Operating income βˆ’$15.4M βˆ’$9.0M βˆ’$22.4M βˆ’$47.3M βˆ’$58.9M βˆ’$128M βˆ’$147M βˆ’$173M βˆ’$136M βˆ’$82.1M
Interest expense $5.4M β€” β€” $9.9M $12.4M $7.1M $5.5M $16.6M $24.9M $45.9M
Pretax income βˆ’$30.9M βˆ’$4.6M βˆ’$30.2M βˆ’$57.1M βˆ’$78.8M βˆ’$144M βˆ’$152M βˆ’$187M βˆ’$162M βˆ’$143M
Income tax βˆ’$4.6M βˆ’$0.0M βˆ’$1.4M βˆ’$0.2M $0.1M βˆ’$1.1M βˆ’$0.7M βˆ’$0.3M $0.1M βˆ’$0.0M
Net income βˆ’$29.9M βˆ’$2.3M βˆ’$29.0M βˆ’$57.0M βˆ’$79.0M βˆ’$143M βˆ’$151M βˆ’$187M βˆ’$162M βˆ’$143M
Net income to common β€” βˆ’$2.3M βˆ’$42.5M βˆ’$57.0M βˆ’$79.0M βˆ’$143M βˆ’$151M βˆ’$187M βˆ’$162M βˆ’$143M
Diluted EPS βˆ’$3.49 βˆ’$1.08 βˆ’$1.20 βˆ’$1.09 βˆ’$1.18 βˆ’$1.49 βˆ’$1.46 βˆ’$1.54 βˆ’$1.13 βˆ’$0.96
Diluted shares 0.01B 0.01B 0.04B 0.05B 0.07B 0.10B 0.10B 0.12B 0.14B 0.15B
Cash flow
Cash from operations βˆ’$10.0M βˆ’$8.7M βˆ’$25.6M βˆ’$33.1M βˆ’$46.4M βˆ’$73.3M βˆ’$75.1M βˆ’$78.5M βˆ’$44.7M $45.2M
Capital expenditure $8.9M $7.6M $6.5M $13.0M $23.1M $68.5M $49.5M $80.5M $83.2M $42.5M
Free cash flow βˆ’$18.9M βˆ’$16.3M βˆ’$32.1M βˆ’$46.2M βˆ’$69.5M βˆ’$142M βˆ’$125M βˆ’$159M βˆ’$128M $2.8M
Depreciation and amortization $12.4M $7.5M $6.8M $7.6M $10.9M $26.8M $41.2M $56.1M $78.4M $77.5M
Stock-based compensation $1.6M $4.0M $5.3M $11.0M $17.7M $36.5M $40.6M $81.2M $73.3M $73.7M
Acquisitions β€” β€” $15.1M β€” β€” $62.1M β€” $55.0M $0.0M $0.0M
Share buybacks β€” β€” β€” β€” β€” $25.0M β€” β€” β€” β€”
Dividends and buybacks β€” β€” β€” β€” β€” $25.0M β€” β€” β€” β€”
Balance sheet
Cash and short-term investments $19.6M $22.5M $29.1M $47.1M $108M $187M $84.7M $221M $139M $161M
Total debt $49.3M $42.9M $49.3M $61.2M $46.3M $327M $379M $515M $578M $630M
Current assets $72.8M $66.5M $75.5M $108M $184M $331M $256M $451M $417M $451M
Current liabilities $40.1M $29.7M $30.6M $36.4M $58.3M $101M $139M $158M $153M $219M
Inventory $30.1M $27.3M $28.8M $34.9M $46.0M $91.7M $102M $137M $175M $169M
Property and equipment, net $15.1M $12.7M $13.2M $19.7M $36.7M $87.4M $102M $150M $156M $135M
Goodwill $0.0M β€” $13.9M $13.9M $13.9M $39.7M $47.4M $73.0M $71.0M $75.2M
Intangible assets $5.7M $5.2M $26.4M $25.6M $24.7M $85.3M $82.8M $102M $93.5M $93.5M
Total assets $94.2M $84.7M $129M $170M $261M $572M $521M $805M $776M $791M
Total liabilities $136M $111M $112M $126M $131M $491M $556M $727M $790M $779M
Shareholders' equity βˆ’$41.5M βˆ’$26.7M $17.6M $43.6M $130M $80.7M βˆ’$34.7M $78.1M βˆ’$14.2M $12.4M
Margins
Gross margin 63.3% 67.1% 69.0% 68.4% 70.8% 64.9% 66.4% 64.3% 69.4% 69.6%
Operating margin βˆ’12.8% βˆ’8.8% βˆ’24.5% βˆ’41.7% βˆ’40.6% βˆ’52.7% βˆ’41.9% βˆ’36.0% βˆ’22.3% βˆ’10.7%
EBITDA margin βˆ’2.5% βˆ’1.5% βˆ’17.1% βˆ’35.0% βˆ’33.1% βˆ’41.7% βˆ’30.2% βˆ’24.3% βˆ’9.4% βˆ’0.6%
Net margin βˆ’24.9% βˆ’2.3% βˆ’31.6% βˆ’50.3% βˆ’54.5% βˆ’58.8% βˆ’43.1% βˆ’38.7% βˆ’26.5% βˆ’18.8%
FCF margin βˆ’15.7% βˆ’16.0% βˆ’35.0% βˆ’40.7% βˆ’48.0% βˆ’58.3% βˆ’35.5% βˆ’33.0% βˆ’20.9% 0.4%
Returns
Return on capital β€” β€” βˆ’46.9% βˆ’64.7% βˆ’67.9% βˆ’45.9% βˆ’44.7% βˆ’36.8% βˆ’25.3% βˆ’13.5%
Return on capital employed βˆ’28.4% βˆ’16.4% βˆ’22.7% βˆ’35.4% βˆ’29.0% βˆ’27.2% βˆ’38.5% βˆ’26.8% βˆ’21.9% βˆ’14.4%
Return on equity β€” β€” β€” βˆ’186.3% βˆ’91.1% βˆ’135.9% βˆ’657.7% βˆ’859.1% βˆ’507.1% β€”
Return on assets βˆ’31.8% βˆ’2.6% βˆ’27.1% βˆ’38.1% βˆ’36.6% βˆ’34.3% βˆ’27.7% βˆ’28.1% βˆ’20.5% βˆ’18.3%
Return on tangible equity β€” β€” β€” βˆ’1,380.5% βˆ’86.6% β€” β€” β€” β€” β€”
Growth
Revenue growth β€” βˆ’15.4% βˆ’9.9% 23.7% 27.7% 67.9% 44.3% 37.4% 26.8% 25.0%
Share count change β€” 54.8% 165.9% 47.9% 28.3% 43.5% 7.5% 17.3% 17.9% 5.0%
Financial health
Debt / equity β€” β€” 2.8x 1.4x 0.4x 4.1x β€” 6.6x β€” 50.7x
Interest coverage βˆ’2.9x β€” β€” βˆ’4.8x βˆ’4.8x βˆ’18.0x βˆ’26.7x βˆ’10.4x βˆ’5.5x βˆ’1.8x
Current ratio 1.8x 2.2x 2.5x 3.0x 3.2x 3.3x 1.8x 2.9x 2.7x 2.1x
Quick ratio 1.1x 1.3x 1.5x 2.0x 2.4x 2.4x 1.1x 2.0x 1.6x 1.3x
Capital allocation
Capex / revenue 7.4% 7.5% 7.1% 11.5% 16.0% 28.2% 14.1% 16.7% 13.6% 5.6%
Stock comp / revenue 1.4% 3.9% 5.8% 9.7% 12.2% 15.0% 11.6% 16.8% 12.0% 9.6%
Quality scores
Piotroski F-score β€” 4.0 4.0 3.0 5.0 3.0 3.0 4.0 4.0 5.0
Altman Z'' βˆ’15.0 βˆ’15.8 βˆ’11.4 βˆ’9.5 βˆ’5.3 βˆ’3.1 βˆ’6.3 βˆ’3.5 βˆ’4.3 βˆ’4.6
Accruals ratio βˆ’21.2% 7.2% βˆ’3.1% βˆ’16.0% βˆ’15.1% βˆ’16.7% βˆ’13.9% βˆ’16.3% βˆ’14.9% βˆ’24.1%

Source: SEC EDGAR XBRL filings (CIK 0001350653). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open